Warren-based Tevogen Bio Inc. has appointed Mittul Mehta as chief information officer, according to a Tuesday announcement.
Mehta will also head Tevogen.ai, the newly launched initiative focused on harnessing the potential of artificial intelligence for the enhancement of drug discovery, development, manufacturing, distribution and patient access.
With over 20 years of experience in information technology and almost a decade in senior management roles, Mehta brings with him a diversified background in IT. His expertise encompasses a wide range of responsibilities, from leading cross-functional teams to architecting solutions.
Mehta most recently served as senior vice president, global head of platforms security, mobility & cloud security at Jefferies LLC, where he played a pivotal role in enterprise strategy.
Mehta brings a wealth of experience across different industries and roles at companies that include Avanade Inc., Macy’s Inc., MetLife Inc. and Microsoft Corp. His achievements at these companies underscore his ability to align technology with business goals while building teams to navigate complex projects and changing priorities.
“Mr. Mehta’s significant experience in managing and mentoring teams is complemented by his strong partnerships with major technology providers. As Tevogen Bio expands its horizons with the Tevogen.ai initiative, we believe Mr. Mehta’s strategic acumen and leadership skills will play a crucial role in helping Tevogen Bio harness the potential of AI for the future of health care,” Dr. Ryan Saadi, CEO of Tevogen Bio, said.
